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Abstract The twin-arginine translocation (Tat) system cata-
lyzes the transport of folded proteins across the bacterial plasma
membrane or the chloroplast thylakoid membrane. In Escheri-
chia coli and most other species, three important tat genes have
been identi¢ed but the structure and mechanism of this system
are poorly understood; the role and location of TatA are par-
ticularly unclear. In this report we have used site-speci¢c muta-
genesis to probe the signi¢cance of conserved features of the
related TatA/B subunits. We ¢nd that an apparent ‘hinge’ re-
gion between the transmembrane (TM) span and an adjacent
amphipathic region is important in both proteins, in that sub-
stitution of turn-inducing residues inhibits the export of a nat-
ural Tat substrate. Surprisingly, large-scale mutagenesis of the
conserved amphipathic regions of TatA and TatB leads only to
minor e¡ects on Tat-dependent export suggesting that this par-
ticular feature is not central to the translocation mechanism.
This domain is, however, critical for the translocation process
and we identify Gly/Pro residues in these regions of TatA/B that
are essential for e⁄cient export.
/ 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The twin-arginine translocation (Tat) system is a protein
transporter found in the thylakoid membranes of photosyn-
thetic organisms and the plasma membranes of most free-liv-
ing bacteria (reviewed in [1,2]). It recognizes substrates bear-
ing cleavable signal peptides that contain a twin-arginine
motif which is usually essential for e⁄cient translocation
[3,4]. Thereafter, the substrates are transported into the thy-
lakoid lumen or periplasm and the precursor protein is pro-
cessed to the mature size. Operating in parallel with Sec-type
protein transport systems, the Tat system is completely di¡er-
ent in key mechanistic respects. Whereas Sec-type systems
invariably transport proteins in a largely unfolded state (re-
viewed in [2]), there is now convincing evidence that the Tat
system is able to transport fully-folded proteins across the
thylakoid membrane and bacterial plasma membrane [5^11].
The primary substrates for the Tat system in Escherichia coli
are a series of periplasmic redox proteins that contain FeS,
molybdopterin or other complex cofactors [7,8]. These cofac-
tors are inserted in the cytosol by complex pathways which
must necessitate the subsequent export of the protein in a
largely, if not completely folded state.
To date, three core tat genes (tatABC) have been identi¢ed
in bacteria [9^12] and homologous genes encoding the chloro-
plastic Tat subunits have been characterized in plants [13^15].
Puri¢cation of a Tat complex from detergent-solubilized
E. coli membranes [16] yields a ca. 650 kDa complex contain-
ing only TatABC, further emphasizing the involvement of
only three protein constituents. However, this complex has
not been shown to be active and the involvement of further
Tat subunits cannot be ruled out at present. The known Tat
subunits are not related to any other gene products and the
energetics of translocation are also unique among known pro-
tein transporters: the thylakoidal system is known to require
the vpH across the membrane but not to require any form of
nucleoside triphosphate hydrolysis [17,18]. However, these un-
usual aspects, combined with the relatively recent discovery of
the system in bacteria, have also meant that the structure and
mechanism of the system are rather poorly understood.
Nevertheless, the ¢rst details of the Tat system organization
have appeared during the last year or so. First, it has been
shown that TatB and TatC form a structural and functional
unit within the E. coli Tat system, being tightly associated in a
1:1 ratio and remaining active even as a TatB^TatC chimera
[16]. Secondly, studies on the thylakoidal system [19,20] indi-
cate that this TatB^TatC complex forms the initial binding
site for substrates, with TatA being recruited at a later step in
the overall translocation process. Thirdly, mutagenesis of
TatC has revealed the presence of critical residues on the cis
side of the membrane, consistent with a role in substrate bind-
ing [21,22].
While the above studies have started to explore the struc-
ture and function of the Tat system, many details have yet to
be resolved. In particular, the functions of the TatA protein
are as yet unknown and it is equally unclear how it carries out
a function distinct from TatB despite being homologous in
certain regions. Several highly conserved TatA/B characteris-
tics have been pinpointed as potentially important, but their
relevance has not been addressed experimentally. The mode
by which TatA interacts with the TatBC core is also poorly
understood at the present time. In this study we have used
site-speci¢c mutagenesis to probe the structure^function rela-
tionships in TatA and TatB. The data illustrate that a highly
conserved ‘hinge’ region plays an important function in both
TatA and TatB whereas another conserved TatA/TatB fea-
ture, an amphipathic helical region, is surprisingly unimpor-
tant.
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2. Materials and methods
2.1. Bacterial strains, plasmids and growth conditions
E. coli strain MC4100 [23] was the parental strain; vtatAE, vtatB,
vtatC, vtatABCDE have been described before [10^12,24], and arabi-
nose-resistant derivatives were used as described [25]. Plasmid pBAD-
ABC has been described before [25]. E. coli was aerobically grown at
37‡C in modi¢ed low salt Luria broth (lsLB) [26], or anaerobically in
lsLB-GT medium, consisting of lsLB supplemented with glycerol
(0.5%), trimethylamine N-oxide (TMAO; 0.4%), and ammonium mo-
lybdate (1 WM), or in minimal TMAO/glycerol medium [25]. Medium
supplements were used at the following ¢nal concentrations: ampicil-
lin, 100 Wg/ml; kanamycin, 50 Wg/ml; 1 mM isopropyl-L-D-thiogalac-
topyranoside (IPTG); arabinose 200 WM.
Site-speci¢c mutagenesis was used to generate a vector that encoded
the tat operon within pBAD-ABC with point mutations in the tatA or
B genes, using the Quickchange1 mutagenesis system (Stratagene)
according to the manufacturer’s instructions. The e¡ects of these mu-
tations were analyzed using an assay for TMAO reductase activity as
detailed below. For studies on the e¡ects of these mutations on green
£uorescent protein (GFP) export, the tatABC sequences were removed
from pBAD-ABC using NheI and XbaI, and cloned into the pEXT22
vector [27] using the XbaI site, generating pEXT-ABC and mutant
derivatives which are compatible with pJDT1 encoding TorA-GFP.
An identical strategy was used to analyze TatC mutants in a previous
study [21] and further details are given in this paper.
2.2. Cell fractionations
Cells were grown aerobically (in lsLB medium) or anaerobically (in
lsLB-GT medium) in the presence or absence of IPTG or arabinose
(as stated in the text), and periplasm and spheroplasts were prepared
by the ethylenediamine tetraacetic acid (EDTA)/lysozyme/cold os-
moshock procedure [28]. Spheroplasts were lysed by sonication, and
intact cells and cellular debris were removed by centrifugation (5 min
at 10 000Ug). Membranes were separated from the cytoplasmic frac-
tion by centrifugation (30 min at 250 000Ug). Protein concentration
was determined using a BCA-linked assay (Pierce). Protein fractions
were separated on a 10% non-denaturing polyacrylamide gel and an-
alyzed for TorA activity [8].
3. Results
3.1. Conserved residues in TatA and TatB
TatA and TatB are homologous proteins that carry out
very di¡erent functions in the E. coli Tat system. Each con-
tains a single transmembrane (TM) helix (N-terminus on the
periplasmic side of the membrane), and this span is followed
by a predicted amphipathic K-helical region on the cytoplas-
mic face [1,2]. TatA is a relatively small protein (89 residues)
with only a short cytoplasmic domain following the amphi-
pathic region, whereas TatB is larger (171 residues) with more
extended amphipathic and cytoplasmic domains. Fig. 1 shows
an alignment of various bacterial TatA and TatB proteins, in
which TM spans and amphipathic regions are indicated and
conserved residues or regions boxed or indicated by asterisks.
The sequences exhibit surprisingly little sequence homology
and only a few residues are invariant throughout bacteria
(shown in bold). These include the FG sequence just after
the TM span in TatA and the GP sequence at a similar posi-
tion in TatB. It should, however, be noted that these motifs
are not absolutely diagnostic of TatA/TatB identity since in
plants, the Tha4 and Hcf106 proteins (believed to be homol-
ogous to TatA/TatB, respectively) each contain both motifs
(i.e. the sequence FGP).
The residues in E. coli TatA and TatB targeted for muta-
genesis are shown underlined in Fig. 1. We focused particular
attention on the FG sequence in TatA and the GP sequence in
TatB since the highly conserved turn-inducing Gly/Pro resi-
dues may be indicative of a ‘hinge’ function for this region.
We also substituted the Glu8 residue in TatB (by both Ala
and Gln) since this residue is totally conserved throughout
TatB proteins and apparently located in the TM span. The
presence of an acidic residue in such a position raises the
possibility of a role in proton conductance, and the thylakoi-
dal Tat system is indeed driven by a proton-motive force
[17,18]. These are in fact the only invariant residues among
TatA/TatB sequences but others are highly conserved and
several were substituted (by alanine) at positions indicated
in Fig. 1. Mutations were made within the tatABC operon
cloned into the arabinose-inducible pBAD24 plasmid, as
used previously for studies on TatC function [21]. The TatC
protein encoded by this plasmid (pBAD-ABC) contains a
C-terminal Strep II tag to aid identi¢cation of TatC and pu-
ri¢cation of the complex by Streptactin a⁄nity chromatogra-
phy. The mutated operons were expressed in a vtatABCDE
strain lacking all known Tat components. All of the mutants
were analyzed to assess the levels of TatABC expressed, and
the TatB and TatC levels were found to be similar in all cases
(data not shown). The levels of TatA varied to a slightly
greater extent for unknown reasons.
3.2. Important residues in TatA and TatB
We ¢rst analyzed the export of an authentic Tat substrate,
TMAO reductase (TorA), in cells expressing TatA/B proteins
that contained mutations in the invariant residues. These tests
used a native gel electrophoresis system which was speci¢cally
stained for TMAO reductase activity; the assay is only semi-
quantitative at best but drastic e¡ects on export are readily
apparent. In wild-type cells expressing pBAD-ABC, TorA is
located primarily in the periplasm (P), as expected, whereas
the activity is exclusively in the cytoplasm (C) of vtatABCDE
cells. The data obtained with TatA/B mutants show that TorA
is exported in cells expressing TatA/F20A, TatA/G21A, TatB/
G21A and TatB/P22G. However, a more slowly migrating
form of TorA (denoted TorA*) is observed in each case, in-
dicating an inhibition of export. In the same experiment we
analyzed TatB mutants containing Ala or Gln in place of the
invariant Glu8 residue. Surprisingly, both mutants export
TorA with wild-type e⁄ciency suggesting that this residue
does not play a key role in the export process.
TorA export assays were also conducted with the other
TatA/B mutants generated in this study, but it was found
that more precise information could be obtained using a
TorA-GFP export assay that is described below. However,
the e¡ects of two further mutations are shown in Fig. 2 be-
cause they proved to drastically a¡ect the Tat export process.
These are TatA/G33A and TatB/P26A; Fig. 2 shows that
these mutations severely a¡ect export in that considerable
TorA activity is found in the cytoplasm.
3.3. Export of TorA-FGP in cells expressing mutated TatA/B
subunits
Strains expressing the mutant TatA/B proteins were also
tested for their ability to export a chimeric protein comprising
the TorA signal peptide linked to green £uorescent protein
(GFP). This chimera is exported exclusively by the Tat path-
way [26] and was used to assess the e¡ects of TatC mutations
in an earlier study [21]. The assay is far more quantitative
than the TorA assay and for these experiments we used a
plasmid, pJDT1 [26] encoding TorA-GFP in the arabinose-
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inducible pBAD24 vector, with the mutant tatABC operons
cloned into the compatible, IPTG-inducible pEXT22 vector.
The wild-type tatABC operon in pEXT22 (plasmid pEXT-
ABC) supports e⁄cient export of TorA-GFP in vtatABCDE
cells [21].
Fig. 3A shows assays for the export of TorA-GFP by the
strains expressing mutant Tat proteins, where cells were frac-
tionated and the samples immunoblotted using antibodies to
GFP. In the control assay, GFP is found predominantly as
mature size protein in the periplasmic fraction (lanes P) in
cells expressing both TorA-GFP and pEXT-ABC, as found
previously [21]. No export is observed when pJDT1 is ex-
pressed in the vtatABCDE strain, and the protein instead
accumulates as the precursor form in the cytoplasm and mem-
brane fractions (pJDT1/vtat panel). The upper panels show
the data obtained with mutant TatA proteins. The G2A mu-
tant exhibits a slight export defect, with some of the GFP
found in the cytoplasm and membrane fractions, and substi-
tution of the conserved F20 and G21 residues leads to a
slightly more severe export defect, with more of the majority
of the GFP now in the cytoplasm and membrane. A mild
export defect is also observed with the K24A mutant, whereas
the L25A and F39A mutants support nearly wild-type export
e⁄ciencies. Finally, the export of GFP is almost totally
blocked in the G33A mutant, indicating that this residue is
essential for e⁄cient export of TorA-GFP.
The e¡ects of the TatB mutations are shown in the lower
panel of Fig. 3A. Substitution of the invariant G21 residue by
Ala hardly a¡ects export e⁄ciency at all while the P22G and
P22L mutants exhibit only a moderate export defect. The
result with the P22L is surprising since the same mutation
in the chromosomal tatB gene was found to block export in
E. coli [9]. The likely explanation is that the mutation does not
completely block TatB function and moderate levels of export
activity are sustained by the increased levels of TatB present
in our system due to the higher copy number of the plasmid-
borne tatB gene. Fig. 3B shows a comparison of TatA and
TatB levels in the vtatABCDE strain (lanes tat-), wild-type
E. coli (wt) and the strain expressing the P22L mutant after
induction with IPTG. The data clearly show a signi¢cant in-
crease in Tat subunit levels (typically 10^20-fold over wild-
type levels after quantitation of these blots; not shown). Of
the remaining mutants, L25A and L63A export TorA-GFP
with high e⁄ciency whereas export is almost totally blocked
in the P26A mutant, which is clearly the most drastically
a¡ected of the TatB mutants in terms of export activity.
We conclude from these data that the highly conserved
‘hinge’ regions between the transmembrane spans and pre-
dicted amphipathic regions in TatA and TatB are indeed re-
quired for e⁄cient export but they are by no means essential.
Moreover, substitutions in this region do not have severe ef-
fects on the export of GFP. Much more important, for both
TorA and GFP export, are the G33 residue in TatA and the
P26 residue in TatB.
3.4. Evidence that the amphipathic regions in TatA and TatB
do not play critical roles in export
The TM regions of TatA/B are closely followed by posi-
tively charged regions that are strongly predicted to form
amphipathic K-helices as indicated in Fig. 1. A recent study
has shown these regions to be functionally important since the
TatA and TatB proteins are active after truncation by up to
40 or 70 residues from the C-terminus, respectively, but fur-
ther truncation abolished export competence [29]. Alignments
of TatA/B proteins show that, although the precise positions
of the basic residues in this region are not always absolutely
conserved, the predicted amphipathic character is highly con-
served (data not shown). The invariant FG or GP motifs (in
TatA/B, respectively) lie between these regions.
Fig. 4A shows the locations of basic residues in the relevant
  
 
      
 
   
   
      
 
 
 
 
 
            
 
   
   
      
   
 
                
 
Fig. 1. Primary structures of bacterial TatA/B proteins. The ¢gure
shows an alignment of the amino-terminal regions of TatA/TatB
proteins from E. coli (ECO), Salmonella typhimurium (STY), Helico-
bacter pylori (HPY) and Agrobacterium tumefaciens (ATU). The sin-
gle transmembrane spanning regions and predicted amphipathic re-
gions are indicated and conserved residues are boxed and denoted
by asterisks. The C-terminus of TatB is located in the cytoplasm
since it interacts with the N-terminus of TatC [16] which is known
to be cytoplasmically located [30]. TatA is predicted to adopt the
same topology because it is homologous to TatB. Residues that are
absolutely conserved throughout bacteria are shown in bold; those
mutated in this study are underlined.
Fig. 2. Export of TMAO reductase (TorA) in cells expressing TatA/
B mutants. tatA and tatB mutants in the pBAD-ABC vector were
expressed in the vtatABCDE strain as detailed in Section 2. After
induction with 0.2 M arabinose, cells were fractionated to generate
samples of cytoplasm (C) and periplasm (P). Control samples were
also analyzed: MC4100 wild-type cells expressing the pBAD24 vec-
tor or the vtatABCDE strain as indicated. These samples were elec-
trophoresed on a native polyacrylamide gel followed by staining for
TMAO reductase activity. TorA, mature TMAO reductase; TorA*,
more slowly migrating form that accumulates in the cytoplasm.
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regions of TatA and TatB, and these were substituted in
groups by hydrophilic but uncharged Gln or Asn residues.
TatA mutants lacking three or four Lys residues (as shown)
are denoted TatA/33K and TatA/34K, respectively. Simi-
larly, TatB mutants lacking two Arg or three Lys are denoted
TatB/32R and TatB/33K, respectively. These Tat mutants
were analyzed using the TMAO reductase (TorA) native gel
assay and the data are shown in Fig. 4B. In the control sam-
ple, TorA activity is present in the periplasm of wild-type cells
expressing pBAD-ABC, but in the cytoplasm of the vtat-
ABCDE strain, as expected since this strain lacks all known
Tat components. The remaining panels show that e⁄cient
export is also apparent in all of the mutants. Low levels of
cytoplasmic TorA are apparent in the TatA/34K and TatB/
33K mutants, indicating that these sets of mutations do have
a slight adverse e¡ect, but the data otherwise indicate that the
amphipathic nature of this region can be removed over long
stretches without a¡ecting export in a signi¢cant manner. As
these regions represent possible areas of interaction between
TatA and TatB, we next tested the combined e¡ects of multi-
ple TatA plus TatB mutations; the lower section of Fig. 4B
shows that even a combination of [TatA/34K+TatB/33K], or
[TatA/33K+TatB/32R] fails to severely a¡ect export of
TorA. Export is slightly inhibited with the TatB/33K mutant
since the cytoplasmic form of TorA is more apparent, but the
overall conclusion is that these sets of basic residues do not
play vital roles in the export process. TorA-GFP is similarly
exported with almost wild-type e⁄ciency in all of these mu-
tants (data not shown).
4. Discussion
The Tat system catalyzes a unique form of protein trans-
location process but the actual translocation mechanism is
presently obscure. In this study we have focused attention
on the TatA/B proteins in order to probe the roles of these
subunits, by site-speci¢c mutagenesis of conserved residues in
the E. coli proteins. The TatA/B proteins lack signi¢cant ho-
mology to any other proteins in the database except each
other, and the primary sequences thus yield few clues regard-
ing their functions. It is also unusual that, although TatA and
TatB are homologous proteins, they carry out completely dif-
fering roles and cannot substitute for each other [12]. They are
also positioned very di¡erently in the TatABC complex, since
Fig. 3. Assays for the export of TorA-GFP by cells expressing mu-
tant forms of TatA/B. E. coli tatABC operons encoding mutant
forms of TatA/B were cloned into the pEXT22 vector (generating
pEXT-ABC) and expressed in the E. coli vtatABCDE strain, togeth-
er with a TorA-GFP fusion protein (plasmid pJDT1) as detailed in
Section 2. A: Export assays. The control assays in the upper panel
show, from left to right, a negative control for the GFP antibody in
wild-type MC4100 cells expressing pEXT-ABC but not pJDT1
(pEXT-ABC panel), and the export of TorA-GFP in MC4100 cells
(pJDT1 panel), in MC4100 in the presence of the pEXT22 vector,
in the vtatABCDE strain and in MC4100 in the presence of pEXT-
ABC. Additional panels indicate the identities of the TatA/B mu-
tants analyzed. Cells were fractionated into periplasm, cytoplasm
and membrane fractions (P, C, M) and sodium dodecyl sulfate
(SDS)^polyacrylamide gels were immunoblotted using GFP antibod-
ies. The mobilities of the TorA-GFP precursor protein (pGFP) and
mature GFP are indicated. B: Immunoblot of samples of vtat-
ABCDE cells (’tat-’), wild-type MC4100 cells (’wt’) and cells ex-
pressing the TatB P22L mutation described in A, using antisera
against TatA and TatB. The mobilities of the TatA/B bands are in-
dicated; a polypeptide reacting non-speci¢cally with the TatA anti-
serum is denoted by *.
B
A
Fig. 4. Multiple mutations in the TatA/B amphipathic regions do
not block export. A: Predicted TatA/B amphipathic regions that
were targeted for mutagenesis in this study, and the primary sequen-
ces of the mutant forms, where the substitutions are shown in bold.
Residue numbers are indicated for basic amino acids; further details
are given in the text. B: vtatABCDE cells expressing pBAD-ABC in
which the TatA/B amphipathic regions contained multiple substitu-
tions as detailed in A. The upper panel shows fractionations and
TMAO reductase (TorA) native gels using periplasmic and cytoplas-
mic fractions (P, C) from TatA or TatB mutants. The lower panel
shows the data obtained from cells expressing pBAD-ABC deriva-
tives in which both the TatA and TatB sequences were mutated.
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TatB is a close partner of TatC, present in strictly stoichio-
metric amounts, whereas TatA is present in great molar excess
over TatBC and is much more loosely bound [16].
Very few residues in TatA/B are highly conserved even
among eubacteria, and the identities and positions of these
invariant residues have therefore prompted speculation re-
garding their function. The absolutely conserved P22 residue
in TatB suggests a possible turn-inducing function, and the
presence of invariant Gly residues at essentially identical po-
sitions in both the TatA and TatB proteins (residue 21 in
E. coli) raises other interesting possibilities regarding £exibil-
ity between domains. Our data indicate that these residues are
indeed important for the functioning of the TatA/B proteins
because substitution does adversely a¡ect the Tat-dependent
export of TorA. However, these mutants still export TorA
with reasonable e⁄ciency, and this means that their presence
is not vital. Equally surprising is that substitution of the in-
variant FG sequence in TatA and GP in TatB does not inhibit
the export of a heterologous protein, GFP, to an enormous
extent and this raises the intriguing possibility that these ap-
parent hinge regions may assume greater importance for the
export of larger or more complex proteins (TorA is three
times larger than GFP).
In one sense our data appear to di¡er from those of Weiner
et al. [9], who found that the TatB P22L mutation in the
E. coli D43 mutant was completely export-de¢cient. However,
this may re£ect the di¡ering abundance of the Tat system in
these situations, since the D43 mutant contained a chromo-
somal mutation in the tatB gene whereas mutated TatB is
encoded by a multicopy plasmid in our studies. While our
data show the P22 residue to be important, additional turn-
inducing residues in this region appear to be much more sig-
ni¢cant because substitution of the P26 residue in TatB or the
G33 residue in TatA leads to a major export defect in each
case, with both TorA and TorA-GFP.
Another highly conserved feature of TatA/B proteins is the
presence of a cytoplasmic domain that is strongly predicted to
form an amphipathic helix, which would presumably interact
with the cytoplasmic face of the plasma membrane. In this
study we have mutated many of the positive charges in this
region and we ¢nd that all of these mutants remain highly
e⁄cient in Tat-dependent export. Although not all of the
basic residues were targeted in this study, up to seven basic
residues were removed in some of the studies involving com-
binations of TatA and TatB mutants. Our conclusion is that
this feature does not execute a central function in the trans-
location process. It is, however, of interest that the two most
important residues identi¢ed in this study, G33A in TatA and
P26 in TatB, are probably located in these amphipathic re-
gions which points to a critical role for these domains.
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